Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 130.56x is 3569% above its 5-year average of -3.76x, near the high end of its 5-year range (-1518.40x–130.56x).
As of the fiscal period ended Friday, June 30, 2017. 277.37% above its 12-month average of 34.60x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2017 (2017-06-30): 130.56x.
INTEREST COVERAGE RATIO
130.56x
INTEREST COVERAGE RATIO AVG TTM
34.60x
INTEREST COVERAGE RATIO AVG 3Y
1.93x
INTEREST COVERAGE RATIO AVG 5Y
-3.76x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+277.37%
CURRENT VS 3Y AVG
+6657.68%
CURRENT VS 5Y AVG
+3569.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-1.90x
median of 252 covered companies
CURRENT VS SECTOR MEDIAN
+6953.61%
vs the sector median at left
Corcept Therapeutics Incorporated
Market Cap
$13.19B
Interest Coverage Ratio
130.56x
TTM Avg
34.60x
3Y Avg
1.93x
5Y Avg
-3.76x
Market Cap
$12.95B
Interest Coverage Ratio
-10.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.89B
Interest Coverage Ratio
5.38x
TTM Avg
5.00x
3Y Avg
4.08x
5Y Avg
8.08x
Market Cap
$12.52B
Interest Coverage Ratio
-1.06x
TTM Avg
0.71x
3Y Avg
2.65x
5Y Avg
6.89x
Market Cap
$12.49B
Interest Coverage Ratio
144.35x
TTM Avg
102.58x
3Y Avg
62.73x
5Y Avg
62.73x
Market Cap
$14.16B
Interest Coverage Ratio
-1.69x
TTM Avg
367.76x
3Y Avg
367.76x
5Y Avg
367.76x
Market Cap
$12.17B
Interest Coverage Ratio
1.88x
TTM Avg
1.39x
3Y Avg
1.01x
5Y Avg
1.11x
Market Cap
$12.00B
Interest Coverage Ratio
8.55x
TTM Avg
7.42x
3Y Avg
7.61x
5Y Avg
6.89x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corcept Therapeutics Incorporated (CORT) | $13.19B | 130.56x | 34.60x | 1.93x | -3.76x |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -10.72x | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 5.38x | 5.00x | 4.08x | 8.08x |
| Baxter International Inc. (BAX)vs › | $12.52B | -1.06x | 0.71x | 2.65x | 6.89x |
| Penumbra, Inc. (PEN)vs › | $12.49B | 144.35x | 102.58x | 62.73x | 62.73x |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | -1.69x | 367.76x | 367.76x | 367.76x |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 1.88x | 1.39x | 1.01x | 1.11x |
| Encompass Health Corporation (EHC)vs › | $12.00B | 8.55x | 7.42x | 7.61x | 6.89x |
| Tempus AI, Inc. (TEM)vs › | $14.64B | -3.60x | N/A | N/A | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.79B | N/A | 19.12x | 19.12x | 19.12x |
Interest Coverage
130.6x
Debt/Equity
0.01
Current Ratio
2.86
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2017-06-30 | 130.56x |
| 2017-03-31 | 21.07x |
| 2016-12-31 | 12.21x |
| 2016-09-30 | 6.31x |
| 2016-06-30 | 2.84x |
| 2016-03-31 | 0.97x |
| 2015-12-31 | 2.39x |
| 2015-09-30 | 0.15x |
| 2015-06-30 | -1.51x |
| 2015-03-31 | -5.04x |
| 2014-12-31 | -3.76x |
| 2014-09-30 | -5.65x |
| 2014-06-30 | -6.78x |
| 2014-03-31 | -12.01x |
| 2013-12-31 | -9.17x |
| 2013-09-30 | -8.35x |
| 2013-06-30 | -9.68x |
| 2013-03-31 | -9.59x |
| 2012-12-31 | -8.72x |
| 2012-09-30 | -12.33x |
| 2012-06-30 | -1518.40x |
| 2012-03-31 | -2205.80x |
| 2011-09-30 | -2145.67x |
| 2011-06-30 | -8869.00x |
| 2011-03-31 | -3549.00x |
| 2010-12-31 | -5.26x |
| 2010-09-30 | -1776.25x |
| 2010-06-30 | -2148.33x |
| 2010-03-31 | -3032.00x |
| 2009-12-31 | -1290.75x |
| 2009-09-30 | -1167.50x |
| 2009-06-30 | -813.67x |
| 2009-03-31 | -64.35x |
